Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2022-02-08 00:00:00 ET · period of report 2021-12-30 · accession 0001209191-22-007754 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-08 | 2021-12-30 | PMVP | Kung Winston | COO, CFO | G - Gift | $0.00 | -2,725 | 6,600 | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-30 | G | D | 2,725 | $0.00 | 6,600 | D | — | — | (F1) The reported shares were acquired under the Issuer's stock purchase plan on May 20, 2021. |